Estimates Revisions Theralase Technologies Inc.
Stocks
TLT
CA88337V1004
Advanced Medical Equipment & Technology
|
Market Closed -
Toronto S.E.
19:57:22 25/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1750 CAD | 0.00% |
|
-5.41% | +6.06% |
| 09-15 | Theralase Technologies Commences GLP Toxicology Analysis of Rutherrin | CI |
| 08-29 | Theralase Technologies Inc., Q1 2026 Earnings Call, Jun 09, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
- Stock Market
- Stocks
- TLT Stock
- Consensus Theralase Technologies Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
